# Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

> **NCT02597894** · NA · WITHDRAWN · sponsor: **Jonsson Comprehensive Cancer Center**

## Conditions studied

- Stage III Prostate Adenocarcinoma

## Interventions

- **PROCEDURE:** Biopsy of Prostate
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02597894
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-03-01
- **Primary completion:** 2019-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** P. I. left the Institution. Study never opened
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02597894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02597894, "Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02597894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*